Results 31 to 40 of about 59,863 (274)

Acquired VLDL receptor deficiency in experimental nephrosis [PDF]

open access: yes, 1997
Acquired VLDL receptor deficiency in experimental nephrosis. Nephrotic syndrome (NS) is commonly associated with elevation of plasma very low density lipoprotein (VLDL) and triglyceride concentrations.
Liang, Kaihui, Vaziri, Nosratola D.
core   +1 more source

Alteration in different lipoprotein fractions in chronic renal failure patients

open access: yesMRIMS Journal of Health Sciences, 2016
Background: Chronic renal failure, which is an inevitable terminal pathway of any chronic renal parenchymal disease, is more known for its morbidity than for its mortality.
M Ravi Kumar, Ravindra Kumar
doaj   +1 more source

Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors.

open access: yesJournal of Lipid Research, 1996
The clinical relevance of apoE concentration in lipoprotein fractions should be evaluated. We investigated the impact of the common apolipoprotein (apo) E polymorphism in conjunction with very low density lipoprotein (VLDL) apoE concentration on the ...
K Bohnet   +4 more
doaj   +1 more source

Effect of fenofibrate and atorvastatin on VLDL apoE metabolism in men with the metabolic syndrome

open access: yesJournal of Lipid Research, 2012
We examined the effects of fenofibrate and atorvastatin on very low density lipoprotein (VLDL) apolipoprotein (apo)E metabolism in the metabolic syndrome (MetS). We studied 11 MetS men in a randomized, double-blind, crossover trial.
Esther M.M. Ooi   +4 more
doaj   +1 more source

To Investigate the Effect of Dyslipidemia and Metabolic Function in Coronary Heart Disease with Type 2 Diabetes Mellitus—In the Tertiary Care Center. A Study Protocol

open access: yesJournal of Pharmacy and Bioallied Sciences
Introduction: Type 2 DM is the most common type of diabetes and it is characterized by a combination of insulin resistance and relative insulin shortage caused by pancreatic beta cell failure.
Akansha Singh   +3 more
doaj   +1 more source

Practical Approaches to Managing Dyslipidemia in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

open access: yesJournal of Lipid and Atherosclerosis
Dyslipidemia is a major risk factor for cardiovascular disease, and its impact may be exacerbated when accompanied by metabolic dysfunction-associated steatotic liver disease (MASLD).
Fernando Bril   +3 more
doaj   +1 more source

Moderate dyslipoproteinemia induced inflammation and remodeling HDL and VLDL particles in post-renal transplant patients

open access: yesCurrent Issues in Pharmacy and Medical Sciences, 2017
The aim of this paper was to examine whether moderate dyslipoproteinemia can cause an increase of hsCRP and LPO levels in Tx patients who had received immunosuppressive therapy and were without acute inflammatory diseases. Herein, the lipid levels, hsCRP,
Kimak Elzbieta   +2 more
doaj   +1 more source

Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism

open access: yesJournal of Lipid Research, 2008
Cholesteryl ester transfer protein (CETP) inhibition leads to changes in lipoprotein metabolism. We studied the effect of the CETP inhibitor torcetrapib on VLDL apolipoprotein E (apoE) metabolism.
John S. Millar   +14 more
doaj   +1 more source

Resistance of a very low density lipoprotein subpopulation from familial dysbetalipoproteinemia to in vitro lipolytic conversion to the low density lipoprotein density fraction.

open access: yesJournal of Lipid Research, 1983
In vitro lipolysis of very low density lipoprotein (VLDL) from normolipidemic and familial dysbetalipoproteinemic plasma by purified bovine milk lipoprotein lipase was studied using the combined single vertical spin and vertical autoprofile method of ...
B H Chung, J P Segrest
doaj   +1 more source

Plasma clearance and biodistribution of oxidatively modified 99mTc-ß-VLDL in rabbits

open access: yesBrazilian Journal of Medical and Biological Research, 1997
The biodistribution and removal from plasma (measured as fractional clearance rate, FCR, per hour) of native and oxidatively modified 99mtechnetium-labeled ß-very low density lipoprotein (99mTc-ß-VLDL) were investigated in hypercholesterolemic (HC) and ...
E.L. Silva   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy